Aller au contenu
RécupérationRevue des preuves3 min read

HRV biofeedback for gut disorders: 4 studies, 2 showed symptom relief

Collectif éditorial MoveVitals · Study published · Reading updated

Original paper:The effects of heart rate variability biofeedback on functional gastrointestinal disorders: a scoping review. · Frontiers in physiology · 2025 · Article original ↗

À retenir

A scoping review found only 4 interventional studies of heart rate variability biofeedback in functional gastrointestinal disorders; 2 reported significant symptom improvement and 2 found no significant difference. The studies were mixed in patients and conditions, so the suggestion that at least 6 weeks is needed is tentative.

Study design

Revue des preuves

Reading basis

Published abstract

Reading focus

Design & applicability

Cette explication éditoriale existe en anglais, chinois simplifié et chinois traditionnel. Cette interface affiche la lecture en anglais.

Question de recherche

Functional gastrointestinal disorders cause chronic or recurring gut symptoms without a clear structural cause, and may involve gut-brain imbalance and reduced vagal activity. Heart rate variability biofeedback (HRVB) can influence autonomic activity, so the authors collected the evidence on whether it helps these conditions.

Population et méthode

Scoping review that systematically searched four medical databases and found 4 interventional studies using HRVB in functional gastrointestinal disorders. The abstract does not report the search dates, sample sizes, outcome measures or quality assessment.

Résultats

The authors’ reported results. Read each estimate with its population and uncertainty.

  1. 1
    Only 4 interventional studies qualified, covering both children and adults and different subtypes of functional gut disorder.
  2. 2
    Two of the 4 studies found significant symptom improvement with HRVB; the other 2 found no significant difference.
  3. 3
    From these results the authors suggest at least 6 weeks of HRVB may be needed to see an effect on symptoms.
  4. 4
    They describe the evidence as emerging but promising when HRVB is delivered optimally, and call for better future studies.

Limites et incertitude

  1. 1
    With 4 heterogeneous studies, the findings cannot be combined or compared reliably.
  2. 2
    The 6-week threshold is an interpretation of differing results, not a tested comparison.
  3. 3
    The abstract gives no sample sizes, effect sizes or information on control groups or bias.
  4. 4
    This reading is based on the abstract only.

Mise en perspective

HRV biofeedback (paced breathing guided by a heart-rate display) is low-risk, but this evidence does not show it treats gut disorders. Persistent digestive symptoms should be evaluated by a clinician, and any breathing practice can be an add-on, not a replacement.

Vos données

If you practise HRV biofeedback with a chest strap or watch, log session length and frequency along with your symptoms. Compare resting HRV only under the same conditions (same device, morning, similar sleep), and look for multi-week trends rather than single-session changes.

Comprendre ce type de preuve

Check which designs were included, how searches and bias assessment were conducted, and the last search date. Publication date alone does not make the underlying evidence current.

Résumé structuré des auteurs English

Le résumé original en anglais est reproduit avec attribution sous la licence ouverte indiquée. Il s’agit d’une source, pas d’une interprétation MoveVitals. L’analyse préparée figure ci-dessus ; vérifiez les conclusions importantes dans la source.

Background

Functional Gastrointestinal Disorders (FGID) are a group of symptom-based disorders that occur across the alimentary tract and have a high prevalence globally in both adults and children. These symptoms are chronic and/or recurrent and often have substantial effects on quality of life. Their incidence is tied to multiple factors, including gut-brain axis imbalance, which includes autonomic dysregulation related to a relative withdrawal of vagal activity. Heart rate variability biofeedback (HRVB) is a non-invasive intervention that can influence autonomic activity and has shown benefit for diverse conditions including depression and anxiety, however the evidence of its effect has not yet been systematically assessed in FGIDs. This scoping review aimed to collate and evaluate the available literature regarding HRVB and FGIDs.

Methods

We systematically searched four medical databases. Four interventional studies using HRVB in FGIDs met inclusion criteria.

Results

Studies were heterogeneous, including both paediatric and adult patients, as well different subtypes of FGID. Two of the four studies demonstrated significant symptom improvements from HRVB while the other two found no significant difference.

Discussion

Our findings suggested that at least 6 weeks of HRVB is required to observe an impact on FGID symptoms. We provide recommendations for future studies of HRVB in FGIDs, which are needed. Evidence on HRVB for FGID is still emerging, but appears promising when administered optimally.

Sources et attribution

The effects of heart rate variability biofeedback on functional gastrointestinal disorders: a scoping review.

Pereira AG, Fu L, Xu W, Gharibans AA, O'Grady G.

Frontiers in physiology · 2025-05-22

DOI: 10.3389/fphys.2025.1511391 ↗PubMed · 40476217 ↗Europe PMC · Licence indiquée: cc by ↗

Abstract © the original authors, reproduced under the recorded open licence. Translations support reading; use the English record to check terminology and numerical results. Our methodological interpretation is separate from the authors’ conclusions.

Interprétation éditoriale MoveVitals · contenu éducatif · aucune évaluation clinique individuelle enregistrée

Sources vérifiées 2026-11-01

Guides pratiques

À lire ensemble

·Article de recherche

Short-term HRV was higher during slow breathing in 962 military men, injured or not

In 962 military men (median age 37.6 years), every short-term heart rate variability (HRV) measure was higher during slow breathing at six breaths a minute than during spontaneous breathing, injured or not; in fast resting breathers RMSSD rose from 15.57 to 21.89 ms. It was one session in a fixed order, so it shows an immediate effect, not lasting benefit.

European Journal of Applied Physiology

Explications approfondiesLire l’étude →
·Méta-analyse d’essais

Cold-water immersion: no strength gain, briefly weaker jumps, soreness relief uncertain

Across 22 randomised trials (375 participants, mostly men), one cold-water immersion after exercise did not change maximal isometric strength (g 0.08, 95% CI −0.11 to 0.26) and was followed by weaker jumping straight afterwards (g −0.68), gone by 24–48 hours. Lower soreness and creatine kinase looked favourable but weakened in sensitivity checks, and certainty was low to very low.

PeerJ

Explications approfondiesLire l’étude →
·Revue des preuves

Cold-water immersion after hard exercise: less soreness, better power, no strength gain

In a meta-analysis of 52 randomised trials, cold-water immersion after high-intensity exercise was followed 24 hours later by lower soreness (SMD −0.89), higher perceived recovery (0.66) and better muscular power (0.22), with no effect on strength. Participants could not be blinded, most were men, and many pooled results rest on few studies with high heterogeneity.

Sports Medicine

Explications approfondiesLire l’étude →
·Méthodes et interprétation

Acute:chronic workload ratio: no evidence it can reduce injury risk, authors argue

The authors argue there is no evidence for using the acute:chronic workload ratio (ACWR) in training-load management or to reduce injury risk: no study has properly estimated a causal effect, and the ratio is statistically inaccurate and ambiguous. This is a methodological critique, not a new data analysis, so it does not show that training load is unrelated to injury.

International Journal of Sports Physiology and Performance

Explications approfondiesLire l’étude →
Récupération →